Oral GLP-1s without fasting or reduced efficacy: Delivery approach protects peptide-based drugs from stomach acid

Graphical abstract. Credit: Cell Biomaterials (2026). DOI: 10.1016/j.celbio.2026.100460

Biomedical engineers at Duke University have developed a…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *